Stock LH LABCORP HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Labcorp Holdings Inc.

Equities

LH

US5049221055

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-24 pm EDT 		5-day change 1st Jan Change
199.6 USD +1.67% Intraday chart for Labcorp Holdings Inc. -5.19% -12.16%
May. 23 Some of the biggest splits in Corporate America RE
May. 16 Declaration of Voting Results by Laboratory Corporation of America Holdings CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 16,426 19,826 30,070 20,864 19,297 16,613 - -
Enterprise Value (EV) 1 22,393 24,301 34,110 25,774 23,815 21,321 20,579 20,128
P/E ratio 20.3 x 12.8 x 12.9 x 16.9 x 47.6 x 17.3 x 15.1 x 13.5 x
Yield - - - - - 1.49% 1.53% 1.57%
Capitalization / Revenue 1.42 x 1.42 x 1.87 x 1.4 x 1.59 x 1.3 x 1.24 x 1.19 x
EV / Revenue 1.94 x 1.74 x 2.12 x 1.73 x 1.96 x 1.67 x 1.54 x 1.44 x
EV / EBITDA 11 x 6.6 x 8.11 x 8.82 x 11.5 x 9.62 x 8.73 x 8.06 x
EV / FCF 21.4 x 13.9 x 12.9 x 17.5 x 27.2 x 20.9 x 15.1 x 13.4 x
FCF Yield 4.66% 7.22% 7.77% 5.72% 3.67% 4.78% 6.61% 7.48%
Price to Book 2.17 x 2.12 x 2.85 x 2.06 x 2.42 x 2.01 x 1.81 x 1.66 x
Nbr of stocks (in thousands) 97,100 97,400 95,700 88,600 84,900 84,294 - -
Reference price 2 169.2 203.6 314.2 235.5 227.3 197.1 197.1 197.1
Announcement Date 2/13/20 2/11/21 2/10/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 11,555 13,978 16,121 14,877 12,162 12,799 13,400 13,978
EBITDA 1 2,045 3,681 4,207 2,924 2,072 2,215 2,358 2,496
EBIT 1 1,711 3,332 3,831 2,549 1,715 1,835 1,960 2,111
Operating Margin 14.81% 23.84% 23.76% 17.13% 14.1% 14.34% 14.63% 15.1%
Earnings before Tax (EBT) 1 1,105 2,219 3,127 1,583 568.9 1,339 1,454 1,586
Net income 1 823.8 1,556 2,377 1,279 418 939.6 1,078 1,217
Net margin 7.13% 11.13% 14.75% 8.6% 3.44% 7.34% 8.05% 8.71%
EPS 2 8.350 15.88 24.39 13.97 4.770 11.40 13.05 14.57
Free Cash Flow 1 1,044 1,754 2,649 1,474 874.1 1,020 1,361 1,506
FCF margin 9.04% 12.54% 16.43% 9.91% 7.19% 7.97% 10.16% 10.78%
FCF Conversion (EBITDA) 51.08% 47.64% 62.98% 50.42% 42.18% 46.03% 57.72% 60.34%
FCF Conversion (Net income) 126.79% 112.69% 111.44% 115.24% 209.11% 108.53% 126.19% 123.79%
Dividend per Share 2 - - - - - 2.940 3.013 3.096
Announcement Date 2/13/20 2/11/21 2/10/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 4,056 3,900 3,697 3,606 3,674 3,778 3,034 3,057 3,033 3,177 3,191 3,230 3,228 3,362 3,365
EBITDA 1 997.3 888.4 748.8 681 605.5 590.1 539.6 514.1 482.1 547.2 568.2 565.9 549.1 587.7 591.4
EBIT 1 902.2 794 656.1 589.1 509.9 493.5 448.3 423.9 394.9 452.8 460.7 464.6 448.5 485.9 494.2
Operating Margin 22.24% 20.36% 17.75% 16.34% 13.88% 13.06% 14.78% 13.87% 13.02% 14.25% 14.44% 14.38% 13.89% 14.45% 14.69%
Earnings before Tax (EBT) 1 686 640.1 476.4 421.6 44.5 277.8 205 238.7 -147.1 297.4 361.3 350.1 320.5 378.5 353.7
Net income 1 553 491.6 358.6 352.8 76.1 212.9 188.9 183.3 -167.1 228 264.2 249.4 228.6 273.7 266.5
Net margin 13.63% 12.61% 9.7% 9.78% 2.07% 5.64% 6.23% 6% -5.51% 7.18% 8.28% 7.72% 7.08% 8.14% 7.92%
EPS 2 5.750 5.230 3.870 3.900 0.8600 2.390 2.120 2.110 -1.970 2.690 3.047 2.902 2.711 3.223 3.273
Dividend per Share 2 - - 0.7200 0.7200 - 0.7200 0.7200 - - 0.7200 0.7360 0.7360 0.7360 0.7438 0.7638
Announcement Date 2/10/22 4/28/22 7/28/22 10/27/22 2/16/23 4/25/23 7/27/23 10/26/23 2/15/24 4/25/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,967 4,475 4,040 4,910 4,518 4,707 3,966 3,514
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.918 x 1.216 x 0.9605 x 1.679 x 2.18 x 2.125 x 1.682 x 1.408 x
Free Cash Flow 1 1,045 1,754 2,649 1,474 874 1,020 1,361 1,506
ROE (net income / shareholders' equity) 15.4% 27.7% 28.2% 17.9% 13.2% 15.5% 15.7% 15.7%
ROA (Net income/ Total Assets) 6.53% 12.3% 11% 4.5% 6.44% 6.88% 7.29% 7.79%
Assets 1 12,619 12,641 21,571 28,397 6,490 13,665 14,798 15,629
Book Value Per Share 2 77.80 96.00 110.0 114.0 93.90 98.00 109.0 119.0
Cash Flow per Share 2 14.70 21.80 31.90 21.40 15.20 18.00 20.50 23.30
Capex 1 400 382 460 482 454 466 463 501
Capex / Sales 3.46% 2.73% 2.86% 3.24% 3.73% 3.64% 3.46% 3.58%
Announcement Date 2/13/20 2/11/21 2/10/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Labcorp Holdings Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
197.1 USD
Average target price
239.7 USD
Spread / Average Target
+21.60%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-12.16% 16.61B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.74% 82.59B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-29.66% 69.86B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 26.5B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.06% 17.29B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.47% 15.56B
NATERA, INC. Stock Natera, Inc.
+74.82% 13.2B
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+0.76% 12.75B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.52% 12.6B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+2.74% 12.19B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. LH Stock
  4. Financials Labcorp Holdings Inc.